Cargando…

Hepatic Arterial Phase on Gadoxetic Acid-Enhanced Liver MR Imaging: A Randomized Comparison of 0.5 mL/s and 1 mL/s Injection Rates

OBJECTIVE: To compare gadoxetic acid injection rates of 0.5 mL/s and 1 mL/s for hepatic arterial-phase magnetic resonance (MR) imaging. MATERIALS AND METHODS: In this prospective study, 101 consecutive patients with suspected focal liver lesions were included and randomly divided into two groups. Ea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung Mo, Heo, Suk Hee, Kim, Jin Woong, Lim, Hyo Soon, Shin, Sang Soo, Jeong, Yong Yeon, Kang, Heoung Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Radiology 2014
Materias:	Gastrointestinal Imaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170161/ https://www.ncbi.nlm.nih.gov/pubmed/25246821 http://dx.doi.org/10.3348/kjr.2014.15.5.605

Ejemplares similares

Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver
por: Huh, Jimi, et al.
Publicado: (2015)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

The Role of Three-Dimensional Multidetector CT Gastrography in the Preoperative Imaging of Stomach Cancer: Emphasis on Detection and Localization of the Tumor
por: Kim, Jin Woong, et al.
Publicado: (2015)

Prediction of Decompensation and Death in Advanced Chronic Liver Disease Using Deep Learning Analysis of Gadoxetic Acid-Enhanced MRI
por: Heo, Subin, et al.
Publicado: (2022)

Performance of 3 mL versus 5 mL Discarded Volume for Blood Sampling from Central Venous Access Device
por: Lalthanthuami, HT, et al.
Publicado: (2021)

Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults
por: Febbraro, Salvatore, et al.
Publicado: (2021)

Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Tumors: How We Do It Safely and Completely
por: Kim, Jin Woong, et al.
Publicado: (2015)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Establishment of a Protocol for Determining Gastrointestinal Transit Time in Mice Using Barium and Radiopaque Markers
por: Myagmarjalbuu, Bolormaa, et al.
Publicado: (2013)

Biliary Peritonitis after Radiofrequency Ablation Diagnosed by Gadoxetic Acid-Enhanced MR Imaging
por: Furuta, Akihiro, et al.
Publicado: (2013)

MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-Specific Contrast Agent Gadoxetic Acid
por: Lee, Kyung Hee, et al.
Publicado: (2013)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
por: Yoshida, Morikatsu, et al.
Publicado: (2020)

Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
por: Vargas-Uricoechea, Hernando
Publicado: (2018)

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
por: Schiavon, Michele, et al.
Publicado: (2020)

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles
por: Dashtipour, Khashayar, et al.
Publicado: (2020)

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
por: Bolli, Geremia B., et al.
Publicado: (2021)

Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma
por: Filippelli, Mariaelena, et al.
Publicado: (2022)

Measurement of the kaon mass difference $m_L -m_S$ by the two regenerator method
por: Geweniger, C, et al.
Publicado: (1974)

Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males
por: Hompesch, Marcus, et al.
Publicado: (2021)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

Comparative evaluation of anesthetic efficacy of 1.8 mL and 3.6 mL of articaine in irreversible pulpitis of the mandibular molar: A randomized clinical trial
por: Silva, Stella Agra, et al.
Publicado: (2019)

A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma
por: Cedillo, Mario A., et al.
Publicado: (2019)

Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pancreatic Cancer: A Prospective Pilot Study of Safety Using 10 mL versus 20 mL Alcohol
por: LeBlanc, Julia K., et al.
Publicado: (2013)

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
por: Kovatchev, Boris, et al.
Publicado: (2020)

‘Walking epidural’: comparison of the analgesic efficacy of levobupivacaine 0.0625% + fentanyl 2mcg/mL versus ropivacaine 0.075% + fentanyl 2mcg/mL
por: Mingote, Álvaro, et al.
Publicado: (2023)

Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
por: Wang, Qiang, et al.
Publicado: (2021)

Usefulness of Arterial Subtraction in Applying Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Algorithm to Gadoxetic Acid-Enhanced MRI
por: Youn, Seo Yeon, et al.
Publicado: (2021)

Deep Learning-Based Assessment of Functional Liver Capacity Using Gadoxetic Acid-Enhanced Hepatobiliary Phase MRI
por: Park, Hyo Jung, et al.
Publicado: (2022)

Can men with prostates sized 80 mL or larger be managed conservatively?
por: Lee, Alvin, et al.
Publicado: (2017)

Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL
por: Yu, Neng Chun
Publicado: (2019)

Spotted wolffish (Anarhichas minor) sperm cryopreservation in 5-mL cryovials
por: Beirão, J., et al.
Publicado: (2020)

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis
por: Sugiyama, Kazutoshi, et al.
Publicado: (2019)

Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
por: Warren, Mark L., et al.
Publicado: (2017)

Reusable surface amplified nanobiosensor for the sub PFU/mL level detection of airborne virus
por: Shin, Junghyun, et al.
Publicado: (2021)

Incidental, Small (< 3 cm), Unilocular, Pancreatic Cysts: Factors That Predict Lesion Progression during Imaging Surveillance
por: Kim, Go Eun, et al.
Publicado: (2017)

Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0 ng/mL to 13.0 ng/mL
por: Singh, Gurmukh, et al.
Publicado: (2015)

Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study
por: Cheng, Alice, et al.
Publicado: (2019)

Rapid 500 mL albumin bolus versus rapid 200 mL bolus followed by slower continuous infusion in post-cardiac surgery patients: a pilot before-and-after study
por: Yanase, Fumitaka, et al.
Publicado: (2023)

Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects
por: Woodley, Wendy D., et al.
Publicado: (2021)

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
por: Home, Philip D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2d5au7gmpmk110e86e7k1693u5